SOUTHERN FINANCIAL 1-LC ACCT. For the Period 8/1/I3 to sam3 Note '• Unrealized Gairt Loss is shown as NA" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Cost Unrealized Gain/Loss Est. Annual Inc. Original Cost Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 18.60 16,535.000 307,551.00 290,997.40 16,553.60 BIOGEN IDEC INC 09062X-10-3 BilB 213.02 2,095.000 446,276.90 250,454.95 195,821.95 FACEBOOK INCA 30303M-10-2 FB 41.29 17,500.000 722,645.00 665,000.00 57,645.00 GENERAL ELECTRIC CO 369604-10-3 GE 23.14 23,000.000 532,220.00 498,109.08 36,110.92 17,480.00 3.28% JPM VALUE ADVANTAGE FD -1NSTL FUND 1400 4812A2-58-7 JVAI X 24.98 78,709.170 1,984,580.88 2,000,000.00 (35,419.12) 19,992.12 1.02% Total US Large Cap Equity US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG 8.90 50,000 000 $3,973,273.78 445.c00 00 $3,702,581.43 352,529.00 $270,712.35 92 471 03 $37.472.12 0.94% J.P. Morgan Account Page 5 o' 48 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00023382 SDNY_GM_00292580 EFTA01499594